Stathmin expression in immortalized and oncogene transformed cells

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 573-577

  Mistry, Sucharita J ^a   Atweh, George F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cell proliferation; Oncogene; Stathmin; Transformation

Indexed keywords

STATHMIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; EMBRYO; FIBROBLAST; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RAT;

ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; MICROTUBULE PROTEINS; ONCOGENES; PHOSPHOPROTEINS; RATS; STATHMIN;

EID: 0032921651     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hanash SM, Strahler JR, Kuick R, Chu EHY and Nichols D: Identification of a polypeptide associated with the malignant phenotype in acute leukemia. J Biol Chem 263: 12813-12815, 1988.
2. Melhem RF, Zhu XX., Hailat N, Strahler JR and Hanash SM: Characterization of the gene for a proliferation related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia. J Biol Chem 266: 17747-17753, 1991.
3. Cooper HL., McDuffie E and Braverman R: Human peripheral lymphocyte growth regulation and response to phorbol esters is linked to synthesis and phosphorylation of the cytosolic protein, prosolin. J Immunol 143: 956-963, 1989.
4. Schubart UK, Xu J, Fan W, Genhong C, Goldstein H, Alpini G, Shafrhtz DA, Amat JA, Muhammad F, Norton WT, Owen TA, Lian JB and Stein GS: Widespread differentiation stage-specific expression of the gene encoding phosphoprotein p19 (metablastin) in mammalian cells. Differentiation 51: 21-32, 1992.
5. Ghosh PK., Anderson J, Cohen N, Takeshita K, Atweh GF and Lehowitz P: Expression of the leukemia-associated gene, p18, in normal and malignant tissues; inactivation of expression in a patient with cleaved B cell lymphoma/leukemia. Oncogene 8: 2869-2872, 1993.
6. Brattsand G, Roos G, Marklund U, Ueda H, Landherg G, Nanberg R, Sideras P and Gullberg M: Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells. Leukemia 7: 569-579, 1993.
7. Roos G, Brattsand G, Landberg G, Marklund U, and Gullberg, M: Expression of oncoprotein 18 in human leukemias and lymphomas. Leukemia 7: 1538-1546, 1993.
8. Luo XN, Arcasoy MO, Brickner HE, Mistry S, Schlechter AD and Atweh GF: Regulated expression of p18, a major phosphoprotein of leukemic cells. J Biol Chem 266: 21004-21010, 1991.
9. Mistry S, Luo X and Atweh GF: Transcriptional regulation of phosphoprotein p18 during monocytic differentiation of U937 leukemic cells. Cell Mol Biol Res 41: 103-110, 1995.
10. Feuerstein N, Nishikawa M and Cooper H: Cell-free system studies on the phosphorylation of the 17,000-20,000 dalton protein induced by phorbol ester in human leukemia cells and evidence for a similar event in virally transformed murine fibroblasts. Cancer Res 45: 3243-3251, 1985.
11. Sobel A and Tasjian AH: Distinct patterns of cytoplasmic protein phosphorylation related to regulation of synthesis and release of prolactin by GH cells. J Biol Chem 258: 10312-10324, 1983.
12. Pasmantier R, Danoff A, Fleischer N and Schubart UK: p19, a hormonally regulated phosphoprotein of peptide hormone producing cells: a secretagogue induced phosphorylation in AET-20 mouse pituitary tumor cells and in rat and hamster insulinoma cells. Endocrinology 119: 1229-1238, 1986.
13. Gullberg M, Noreus K, Brattsand G, Friedrich B, and Shingler V: Purification and characterization of a 19 kilodalton intracellular protein, an activation regulated putative protein kinase C substrate of T lymphocytes. J Biol Chem 265: 17499-17505, 1990.
14. Luo XN, Mookerji B, Ferrari A., Mistry S and Atweh GF: Regulation of phosphoprotein p18 in leukemic cells: Cell-cycle regulated phosphorylation by p34cdc2 kinase. J Biol Chem 269: 10312-10318, 1994.
15. Marklund U, Brattsand G, Shingler V and Gullberg M: Serine 25 of oncoprotein p18 is a major cytosolic target for the mitogen-activated protein kinase. J Biol Chem 268: 15039-15049, 1993.
16. Marklund U, Osterman O, Melander H, Bergh A and Gullberg M: The phenotype of a "Cdc2 kinase target site-deficient mutant" of Oncoprotein 18 reveals a role of this protein in cell cycle control. J Biol Che 269: 30626-30635, 1994.
17. Brattsand G, Marklund U, Nylander K, Roos G and Gullberg M: Cell-cycle- regulated phosphorylation of oncoprotein 18 on scr 16, ser 25 and ser 38. Eur J Biochem 220: 359-368, 1994.
18. Beretta L, Dohransky T and Sobel A: Multiple phosphorylation of stathmin: Identification of four sites phosphorylated in intact cells and in vitro by cAMP dependent protein kinase and p34cdc2. J Biol Chem 268: 20076-20084, 1993.
19. +2/calmodulin-dependent kinase IV/Gr- dependent phosphorylation of oncoprotein 18. Mol. Cell Biology 17: 3459-3467, 1997.
20. Belmont LD and Mitchison TJ: Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell 84: 623-631, 1996.
21. Belmont LD, Mitchison TJ and Deacon HW: Catastrophic revelations about Op 18/stathmin. TIBS 21: 197-198, 1996.
22. Marklund U, Larsson N, Melander H, Brattsand G and Gullberg M: Oncoprotein 18 is a phosphorylation responsive regulator of microtubule dynamics. EMBO J 15: 5290-5298, 1996.
23. Larsson N, Melander Gradin H, Marklund U, Osterman O and Gullberg M: G2/M transition requires multisite phosphorylation of oncoprotein 18 by two distinct protein kinase systems. J Biol Chem 270: 14175-14183, 1995.
24. Larsson N, Marklund U, Melander Gradin H, Brattsand G and Gullberg M: Control of microtubule dynamics by oncoprotein 18: Dissection of the regulatory role of multisite phosphorylation during mitosis. Mol Cell Biol 17: 5530-5539, 1997.
25. Borner C, Guadagno SN, Hsiao WWL, Fabbro D, Barr M and Weinstein IB: Expression of four protein kinase C isoforms in rat fibroblasts: Differential alterations in ras-, src-, and fos- transformed cells. J Biol Chem 267: 12900-12910, 1992.
26. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning: A Laboratory Manual, 2nd edn, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989.
27. Zhu XX, Kozarsky K, Strahler JR, Eckerskorn C, Lottspeich F, Melhem R, Lowe J, Fox DA, Hanash SM and Atweh GF: Molecular cloning of a novel human leukemia associated gene. J Biol Chem 264: 14556-14560, 1989.
28. Carmichael J, DeGraff WG, Gazdar JD, Minna JD and Mitchell JB: Evaluation of a tetrazolium-hased semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 47: 943-946, 1987.
29. Luo XN., Reddy JC, Yeyati PL, Idris AH, Hosono S, Haber DA., Licht JD and Atweh GF: The tumor suppressor gene WTI inhibits ras-mediated transformation. Oncogenc 11: 743-750, 1995.
30. Amat JA, Fields KL and Schubart UK: Stage specific expression of phosphoprotein p19 during spermatogenesis in the rat. Mol Reprod Devel 26: 383-390, 1990.
31. Amat JA., Fields KL, and Schubart UK: Distribution of phosphoprotein p19 in rat brain during ontogeny: stage-specific expression in neurons and glia. Devel Brain Res 60: 205-218, 1991.